Works matching IS 21938210 AND DT 2021 AND VI 11 AND IP 5
Results: 32
Real-World Satisfaction with Secukinumab in Clearing the Skin of Patients with Plaque Psoriasis through 24 Months of Follow-Up: Results from US Dermatology Electronic Medical Records.
- Published in:
- Dermatology & Therapy, 2021, v. 11, n. 5, p. 1733, doi. 10.1007/s13555-021-00599-5
- By:
- Publication type:
- Article
Practical Management of Patients with Atopic Dermatitis on Dupilumab.
- Published in:
- Dermatology & Therapy, 2021, v. 11, n. 5, p. 1805, doi. 10.1007/s13555-021-00586-w
- By:
- Publication type:
- Article
Correction to: Efficacy and Safety Trends with Continuous, Long-Term Crisaborole Use in Patients Aged ≥ 2 Years with Mild-to-Moderate Atopic Dermatitis.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Perspectives on the Future Development of Mobile Applications for Dermatology Clinical Research.
- Published in:
- Dermatology & Therapy, 2021, v. 11, n. 5, p. 1451, doi. 10.1007/s13555-021-00604-x
- By:
- Publication type:
- Article
Beyond-Mild Psoriasis: A Consensus Statement on Calcipotriol and Betamethasone Dipropionate Foam for the Topical Treatment of Adult Patients.
- Published in:
- Dermatology & Therapy, 2021, v. 11, n. 5, p. 1791, doi. 10.1007/s13555-021-00600-1
- By:
- Publication type:
- Article
Mast Cell Stabilizers in the Treatment of Rosacea: A Review of Existing and Emerging Therapies.
- Published in:
- Dermatology & Therapy, 2021, v. 11, n. 5, p. 1541, doi. 10.1007/s13555-021-00597-7
- By:
- Publication type:
- Article
Health-Related Quality of Life of Patients with Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma Treated with Pembrolizumab in KEYNOTE-629.
- Published in:
- Dermatology & Therapy, 2021, v. 11, n. 5, p. 1777, doi. 10.1007/s13555-021-00598-6
- By:
- Publication type:
- Article
Selectivity Profile of the Tyrosine Kinase 2 Inhibitor Deucravacitinib Compared with Janus Kinase 1/2/3 Inhibitors.
- Published in:
- Dermatology & Therapy, 2021, v. 11, n. 5, p. 1763, doi. 10.1007/s13555-021-00596-8
- By:
- Publication type:
- Article
Long-Term Proactive Treatment of Plaque Psoriasis with Calcipotriene/Betamethasone Dipropionate Foam Prolongs Remission and Reduces Relapses Irrespective of Patient Baseline Characteristics.
- Published in:
- Dermatology & Therapy, 2021, v. 11, n. 5, p. 1657, doi. 10.1007/s13555-021-00585-x
- By:
- Publication type:
- Article
The Unmet Needs in Atopic Dermatitis Control in Latin America: A Multidisciplinary Expert Perspective.
- Published in:
- Dermatology & Therapy, 2021, v. 11, n. 5, p. 1521, doi. 10.1007/s13555-021-00595-9
- By:
- Publication type:
- Article
A Randomized Double-Blind Parallel-Group Study to Evaluate the Long-Term Effects of a Medical Device Containing 0.3% Octatrienoic Acid in the Treatment of Grade III Actinic Keratosis.
- Published in:
- Dermatology & Therapy, 2021, v. 11, n. 5, p. 1751, doi. 10.1007/s13555-021-00594-w
- By:
- Publication type:
- Article
Recognition and Management of Hereditary Angioedema: Best Practices for Dermatologists.
- Published in:
- Dermatology & Therapy, 2021, v. 11, n. 5, p. 1829, doi. 10.1007/s13555-021-00593-x
- By:
- Publication type:
- Article
Patient Journey in Atopic Dermatitis: The Real-World Scenario.
- Published in:
- Dermatology & Therapy, 2021, v. 11, n. 5, p. 1693, doi. 10.1007/s13555-021-00592-y
- By:
- Publication type:
- Article
Efficacy and Safety of Novel Formulation of Clobetasol Propionate 0.025% Cream in Indian Moderate-to-Severe Psoriasis Patients: Phase-2a, Randomized 3-Arm Study.
- Published in:
- Dermatology & Therapy, 2021, v. 11, n. 5, p. 1717, doi. 10.1007/s13555-021-00591-z
- By:
- Publication type:
- Article
Psoriasis and Cardiometabolic Comorbidities: An Evaluation of the Impact of Systemic Treatments in Randomized Clinical Trials.
- Published in:
- Dermatology & Therapy, 2021, v. 11, n. 5, p. 1497, doi. 10.1007/s13555-021-00590-0
- By:
- Publication type:
- Article
Efficacy and Safety Trends with Continuous, Long-Term Crisaborole Use in Patients Aged ≥ 2 Years with Mild-to-Moderate Atopic Dermatitis.
- Published in:
- Dermatology & Therapy, 2021, v. 11, n. 5, p. 1667, doi. 10.1007/s13555-021-00584-y
- By:
- Publication type:
- Article
Effect of Vitamin-Containing Amino Acid Supplements on Menopausal Symptoms and Age-Related Skin Changes: A Randomised, Double-Blind, Placebo-Controlled Study.
- Published in:
- Dermatology & Therapy, 2021, v. 11, n. 5, p. 1681, doi. 10.1007/s13555-021-00589-7
- By:
- Publication type:
- Article
Key Clinical Adverse Events in Patients with Advanced Basal Cell Carcinoma Treated with Sonidegib or Vismodegib: A Post Hoc Analysis.
- Published in:
- Dermatology & Therapy, 2021, v. 11, n. 5, p. 1839, doi. 10.1007/s13555-021-00588-8
- By:
- Publication type:
- Article
The Use of Real-World Data to Evaluate the Association Between Atopic Dermatitis and Cardiovascular Disease: A Retrospective Claims Analysis.
- Published in:
- Dermatology & Therapy, 2021, v. 11, n. 5, p. 1707, doi. 10.1007/s13555-021-00587-9
- By:
- Publication type:
- Article
Current Trends of Immunotherapy in the Treatment of Cutaneous Melanoma: A Review.
- Published in:
- Dermatology & Therapy, 2021, v. 11, n. 5, p. 1481, doi. 10.1007/s13555-021-00583-z
- By:
- Publication type:
- Article
An Economic Analysis of the Impact of Homecare Drug Administration for Biologic Interventions Available for Plaque Psoriasis in the UK.
- Published in:
- Dermatology & Therapy, 2021, v. 11, n. 5, p. 1635, doi. 10.1007/s13555-021-00582-0
- By:
- Publication type:
- Article
Secukinumab Demonstrated High Effectiveness in Vietnamese Patients with Moderate-To-Severe Plaque Psoriasis in a Real-World Clinical Setting: 16 Week Results from an Observational Study.
- Published in:
- Dermatology & Therapy, 2021, v. 11, n. 5, p. 1613, doi. 10.1007/s13555-021-00581-1
- By:
- Publication type:
- Article
Inadequate Disease Control, Treatment Dissatisfaction, and Quality-of-Life Impairments Among US Patients Receiving Topical Therapy for Atopic Dermatitis.
- Published in:
- Dermatology & Therapy, 2021, v. 11, n. 5, p. 1571, doi. 10.1007/s13555-021-00580-2
- By:
- Publication type:
- Article
Itraconazole Oral Solution for a Case of Infantile Hemangioma: Monitoring the Efficacy by Dermoscopy and MRI.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
Review of the Latest Methods of Epidermolysis Bullosa and Other Chronic Wounds Treatment Including BIOOPA Dressing.
- Published in:
- Dermatology & Therapy, 2021, v. 11, n. 5, p. 1469, doi. 10.1007/s13555-021-00578-w
- By:
- Publication type:
- Article
Baricitinib Rapidly Improves Skin Pain Resulting in Improved Quality of Life for Patients with Atopic Dermatitis: Analyses from BREEZE-AD1, 2, and 7.
- Published in:
- Dermatology & Therapy, 2021, v. 11, n. 5, p. 1599, doi. 10.1007/s13555-021-00577-x
- By:
- Publication type:
- Article
COVE-1: A Phase 2, Open-Label Study to Evaluate Efficacy and Safety and the Optimal Regimen of VP-102, a Proprietary Drug–Device Product Containing Topical Cantharidin (0.7% w/v) Under Occlusion for the Treatment of Common Warts.
- Published in:
- Dermatology & Therapy, 2021, v. 11, n. 5, p. 1623, doi. 10.1007/s13555-021-00576-y
- By:
- Publication type:
- Article
Efficacy and Safety of Platelet-Rich Plasma in Melasma: A Systematic Review and Meta-Analysis.
- Published in:
- Dermatology & Therapy, 2021, v. 11, n. 5, p. 1587, doi. 10.1007/s13555-021-00575-z
- By:
- Publication type:
- Article
Dermatologic Care of Hair in Transgender Patients: A Systematic Review of Literature.
- Published in:
- Dermatology & Therapy, 2021, v. 11, n. 5, p. 1457, doi. 10.1007/s13555-021-00574-0
- By:
- Publication type:
- Article
A Survey of Community Dermatologists Reveals the Unnecessary Impact of Trial-and-Error Behavior on the Psoriasis Biologic Treatment Paradigm.
- Published in:
- Dermatology & Therapy, 2021, v. 11, n. 5, p. 1851, doi. 10.1007/s13555-021-00573-1
- By:
- Publication type:
- Article
Psychometric Validation of the Psoriasis Symptoms and Impacts Measure (P-SIM), a Novel Patient-Reported Outcome Instrument for Patients with Plaque Psoriasis, Using Data from the BE VIVID and BE READY Phase 3 Trials.
- Published in:
- Dermatology & Therapy, 2021, v. 11, n. 5, p. 1551, doi. 10.1007/s13555-021-00570-4
- By:
- Publication type:
- Article
Dupilumab Demonstrates Rapid and Consistent Improvement in Extent and Signs of Atopic Dermatitis Across All Anatomical Regions in Pediatric Patients 6 Years of Age and Older.
- Published in:
- Dermatology & Therapy, 2021, v. 11, n. 5, p. 1643, doi. 10.1007/s13555-021-00568-y
- By:
- Publication type:
- Article